Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ACST Acasti Pharma Inc

3,37

0,00 (0,00%)

Zuletzt aktualisiert: 01:00:00

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Acasti Pharma (NASDAQ:ACST)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Acasti Pharma Charts.

Acasti Pharma (NASDAQ:ACST)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Acasti Pharma Charts.

News Acasti Pharma Inc

Form 8-K - Current report
Montag 28 Oktober 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 25 Oktober 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Mittwoch 16 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Dienstag 8 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Dienstag 8 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Dienstag 8 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Dienstag 8 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Dienstag 8 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Dienstag 8 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 30 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 25 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Freitag 6 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Acasti Pharma Inc News-Artikel

Vertex Pharmac Dl 01

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen